Skip to main navigation Skip to search Skip to main content

A possible effect of methylphenidate on state anxiety: A single dose, placebo controlled, crossover study in a control group

  • Aviv Segev
  • , Hila Zahava Gvirts
  • , Kevin Strouse
  • , Naama Mayseless
  • , Hagar Gelbard
  • , Yael Doreen Lewis
  • , Yael Barnea
  • , Kfir Feffer
  • , Simone G. Shamay-Tsoory
  • , Yuval Bloch

Research output: Contribution to journal › Article › peer-review

16 Scopus citations

Abstract

Methylphenidate affects state-anxiety in ADHD patients. The current study examines the effect of Methylphenidate on state-anxiety in healthy subjects. In a cross-over, randomized, controlled, double-blind study, 36 healthy subjects received either Methylphenidate or placebo. As a group, no change in state-anxiety was detected with Methylphenidate. However, participants reporting higher anxiety levels experienced a significant and specific state-anxiety reduction following Methylphenidate. Moreover, a strong negative correlation was found between the initial-level of anxiety and net-change in state-anxiety. These changes were unrelated to self-perceived attention levels. Our results point to the state-dependent effects of Methylphenidate on anxiety.

Original languageEnglish
Pages (from-to)232-235
Number of pages4
JournalPsychiatry Research
Volume241
DOIs
StatePublished - 30 Jul 2016
Externally publishedYes

Keywords

  • ADHD
  • Attention
  • Cognitive enhancer

Fingerprint

Dive into the research topics of 'A possible effect of methylphenidate on state anxiety: A single dose, placebo controlled, crossover study in a control group'. Together they form a unique fingerprint.

Cite this